Business Context and Reporting Period
Company: United States Antimony Corporation (UAMY)
Filing Type: Form 8-K (Current Report)
Date of Report: March 6, 2026
Principal Event: Notice of uplisting of common stock from NYSE American to the New York Stock Exchange (NYSE).
Key Financial Metrics
This filing is a current report regarding a corporate governance and listing event. It does not contain financial statements, revenue figures, profit data, cash flow metrics, debt levels, or liquidity ratios. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
- Listing Transfer: The NYSE approved the uplisting of the Company's common stock from NYSE American to the NYSE.
- Trading Symbol: The ticker symbol "UAMY" will remain unchanged.
- Effective Date: Trading on the NYSE is expected to commence on March 11, 2026.
- Continuity: The stock will continue to trade on NYSE American until the transfer is complete and will remain listed on the NYSE Texas Exchange.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the transfer. It includes a standard cautionary note regarding forward-looking statements, noting that actual results may differ materially from expectations due to various risks and uncertainties.
Risks and Contingencies: The document explicitly states that forward-looking statements are subject to risks described in the Company's Form 10-K, Form 10-Q, and Form 8-K filings. The Company disclaims any obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the commencement of trading on the NYSE on March 11, 2026.
- Confirm the continued listing status on NYSE Texas and NYSE American during the transition period.
- Review the attached Press Release (Exhibit 99.1) for specific details on the strategic rationale for the uplisting.
- Consult the most recent Form 10-K or 10-Q for actual financial performance data, as this 8-K contains none.